Iguana Healthcare Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Iguana Healthcare Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-200,000	Closed	-$1.1M	–	108
2016 Q1	$1.1M	Buy	+200,000	New	+$752K	0.4%	55
2015 Q3	–	Sell	-200,000	Closed	-$3.02M	–	88
2015 Q2	$3.02M	Hold	200,000	–	–	0.95%	35
2015 Q1	$3.2M	Buy	200,000 +20,000	+11%	+$356K	1.35%	28
2014 Q4	$3.21M	Buy	180,000 +30,000	+20%	+$374K	1.55%	25
2014 Q3	$1.51M	Buy	+150,000	New	+$1.82M	0.8%	44

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Iguana Healthcare Management's PETX Position: Q2 2016 in Review

Iguana Healthcare Management sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2016, closing a stake of 200,000 shares — an estimated $1.1M sold.

Iguana Healthcare Management first reported a position in PETX in Q3 2014 and held it in 5 quarters. The position peaked at $3.21M in Q4 2014. 100 funds tracked by Wall St. Rank hold PETX as of Q2 2016.

Iguana Healthcare Management reported no remaining Aratana Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
Iguana Healthcare Management sold 200,000 Aratana Therapeutics, Inc. shares in Q2 2016, an estimated $1.1M.
Iguana Healthcare Management first reported a position in Aratana Therapeutics, Inc. in Q3 2014 and held it in 5 quarters.
Iguana Healthcare Management's Aratana Therapeutics, Inc. position peaked at $3.21M in Q4 2014.
100 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2016.

Based on Iguana Healthcare Management's 13F filing for Q2 2016, filed 15 Aug 2016.